Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. (2012)
Attributed to:
Reducing cardiovascular risk with dietary flavonoids in post menopausal women with Type 2 diabetes
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/dc11-1443
PubMed Identifier: 22250063
Publication URI: http://europepmc.org/abstract/MED/22250063
Type: Journal Article/Review
Volume: 35
Parent Publication: Diabetes care
Issue: 2
ISSN: 0149-5992